Recombinant Human RECK His-tag Protein, CF Summary
Product Specifications
When Recombinant Human RECK His-tag (Catalog # 10236-RE) is immobilized at 2 µg/mL (100 µL/well), Biotinylated Recombinant Human TEM5/GPR124 His-tag binds with an ED50 of 0.7-4.9 µg/mL.
Gly27-Pro941, with a C-terminal 6-His tag
Analysis
Product Datasheets
Carrier Free
CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.
In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.
10236-RE
Formulation | Lyophilized from a 0.2 μm filtered solution in Tris and NaCl. |
Reconstitution | Reconstitute at 250 μg/mL in water. |
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage: | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Scientific Data
When Recombinant Human RECK His-tag (Catalog # 10236-RE) is immobilized at 2 μg/mL (100 μL/well), Biotinylated Recombinant Human TEM5/GPR124 His-tag binds with an ED50 of 0.7-4.9 μg/mL.
2 μg/lane of Recombinant Human RECK His-tag was resolved with SDS-PAGE under reducing (R) and non-reducing (NR) conditions and visualized by Coomassie® Blue staining, showing a band at ~110 kDa under reducing conditions.
Reconstitution Calculator
Background: RECK
Reversion-inducing cysteine-rich protein with Kazal motifs (RECK), also known as Suppressor of tumorigenicity 15 protein (ST15), is a 971 amino acid highly conserved protein that serves as an important mediator of tissue remodeling (1). The multi-domain protein includes hydrophobic regions at the N- and C-termini that correspond to a signal domain and GPI anchoring site, respectively (2). Internally, there are three serine protease inhibitor-like (SPI) domains and two regions with EGF-like repeats (2). The N-terminal region also contains a cysteine-rich domain essential for MMP (3) and Wnt7 binding (4, 5). RECK is normally expressed in all human and mammalian cells (2, 6) while undetectable or downregulated in malignant and cancer cells (1, 2). There is a strong correlation with expression of RECK in several cancers including colorectal, breast, and pancreatic making it a prognostic marker of interest (1, 3, 7-9). Polymorphisms in RECK leads to increased cancer susceptibility (10). RECK's ability to bind several proteins confers complex functionality. RECK is known to bind and inhibit MMPs (1, 2, 11), interact with ADAMTS10 (12), modulate Notch signaling (13), promote p53 signaling (14) and act as a selective Wnt7 receptor through binding of Gpr124 (4). RECK acts as a tumor suppression gene by inhibiting angiogenesis, invasion, and metastasis through its role in the regulation and signaling within the extracellular matrix (1, 3, 6). Through its interaction with Wnt7, RECK promotes angiogenesis and regulates the blood-brain barrier in CNS by mediating canonical Wnt/beta-catenin signaling (4).
- Alexius-Lindgren, M. et al. (2014) Anticancer Res. 34:3867.
- Takahashi, C. et al. (1998) Proc. Natl. Acad. Sci. U.S.A. 95:13221.
- Clark, J.C.M. et al. (2007) Cancer Mestast. Rev. 26:675.
- Vallon, M. et al. (2018) Cell Reports. 25:339.
- Cho, C. et al. (2019) Elife. 8:e47300.
- Oh, J. et al. (2001) Cell. 107:789.
- Takeuchi, T. et al. (2004) Clin. Cancer Res. 10:5572.
- Zhang, G. et al. (2012) Cancer Sci. 103:1084.
- Masui, T. et al. (2003) Clin. Cancer Res. 9:1779.
- Chung, T.T. et al. (2012) PLoS ONE. 7:e33517.
- Miki, T. et al. (2007) J. Biol. Chem. 282:12341.
- Matsuzaki, T. et al. (2018) Biol. Open 7:bio033985.
- Muraguchi, T. et al. (2007) Nat. Neurosci. 10:838.
- Lui, Y. et al. (2018) J. Cell. Biochem. 119:3058.
FAQs
No product specific FAQs exist for this product, however you may
View all Proteins and Enzyme FAQsReviews for Recombinant Human RECK His-tag Protein, CF
There are currently no reviews for this product. Be the first to review Recombinant Human RECK His-tag Protein, CF and earn rewards!
Have you used Recombinant Human RECK His-tag Protein, CF?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image